Advertisement
Advertisement
NTLA
Intellia Therapeutics, Inc
15.50
USDSponsored
+0.25
+1.64%
Jun 24, 16:00 UTC -4
Closed
After-Market
15.57
+0.07
+0.46%
Intellia Therapeutics, Inc Financial Snapshot
| Market Cap | 2.18B |
| Beta | 1.99 |
| Earnings Per Share (EPS) | -3.83 |
| Price-to-Book (P/B) Ratio | 2.39 |
| Operating Margin | -611.83% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -56.81% |
| Current Ratio | 5.08% |
| Free Cash Flow | -395.87M |
Trending Stocks
Advertisement